REUTERS/Stefan Wermuth/Document Image.Lazard advised Sanofi on its offer, while Guggenheim J and Securities.P. Morgan proved helpful for Bioverativ. J.P. Morgan worked for Celgene and morgan Stanley for Juno also.. Biotech M&A takes off as Sanofi and Celgene spend $20 billion – Biotech offer activity exploded about Monday with French drugmaker Sanofi and U.S.-centered Celgene spending a mixed total greater than $20 billion to include services for hemophilia and cancer with their medicine cabinets. The acquisitions will fuel expectations for the occupied year of mergers and acquisitions as huge drugmakers snap up promising assets from smaller sized rivals to greatly help revive growth.These actions are transported over from the worthiness Modifier program and can require no actions from suppliers to calculate. CMS will gauge the functionality within this category. Finally, the agency included a hardship exemption for all those suffering from major hurricanes in the Gulf Coastline and Puerto Rico in 2017. Presently, those who dropped usage of their EHRs due to the hurricanes, various other organic disasters, or general public health emergencies, they are able to document a hardship exemption to possess their Advancing Treatment Information rating reweighted to reveal the problems. Applications should be submitted by December.